MVF
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Monash IVF Group Limited is a provider of human fertility services and specialised women’s imaging and diagnostic services. The company offers Assisted Reproductive Services (ARS), including in vitro fertilisation (IVF), reproductive genetic services, and tertiary-level prenatal diagnostics. It also delivers specialist diagnostic obstetric and gynaecological ultrasound services. The group operates throughout Australia and Southeast Asia, serving patients experiencing infertility and those requiring advanced diagnostic care. The company’s origins trace back to the work of pioneers who achieved the first IVF pregnancy in the world in 1973. It supports research and development in reproductive medicine and ultrasound through its Research and Education Foundation.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Health Care Equipment & Services Homepage monashivfgroup.com.au
Sector Healthcare IR page monashivfgroup.com.au/investor-centre
Tags
assisted reproductive services, in vitro fertilisation, reproductive genetics, prenatal diagnostics, obstetric ultrasound, gynaecological ultrasound, fertility treatments, reproductive medicine, Monash IVF Group Research and Education Foundation
Press page —

Metrics

Valuation  
Market cap A$ 294.174M
Market cap (USD) $ 199.608M
P/E 39.21
PEG —
P/BV 1.15
P/S 1.09
P/OCF 8.02
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 3.3%
ROI 2.3%
ROIC 5.6%
Profit margin 3.1%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -27.6%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 43.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -11.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 269.459M 271.917M 254.96M 213.59M 192.294M 183.605M 145.417M 151.98M 150.638M 155.182M 156.561M 124.955M 114.012M 96.598M
Net profit 8.326M 25.676M -5.949M 21.966M 18.406M 25.33M 11.726M 19.852M 21.353M 29.619M 28.775M 21.373M 2.581M -14.856M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 0.72 — — — — — — — — — — — — —
P/OCF 7.63 — — — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Appendix 3X Bull 0 Bear 0 Routine
Appendix 3Y Bull 0 Bear 0 Routine
Appendix 3Z Bull 0 Bear 0 Routine

Final Director’s Interest Notice

Appendix 3Z

Rule 3.19A.3

Final Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity Monash IVF Group Limited ABN 90 169 302 309 We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of director

Richard Hugh Davis

Date of last notice

1 June 2020

Date that director ceased to be director

28 October 2026

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

182,067 ordinary shares

  • See chapter 19 for defined terms. 11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice Part 2 – Director’s relevant interests in securities of which the director is not the registered holder Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest

Note: Provide details of the circumstances giving rise to the relevant interest

Number & class of securities

Nil

Part 3 – Director’s interests in contracts Detail of contract

n/a

Nature of interest

n/a

Name of registered holder (if issued securities)

n/a

No. and class of securities to which n/a interest relates

  • See chapter 19 for defined terms. Appendix 3Z Page 2

11/3/2002

Prompts

Monash IVF Group Limited (ticker MVF), listed in Australia.

ETFs Holding Monash IVF Group Limited

ETF Weight in ETF Shares Market value As of
DISV 0.01% 874,466 $ 449.611K Nov 12, 2026
DFIS 0.00% 260,568 $ 133.972K Nov 12, 2026
DFAX 0.00% 144,312 $ 74.199K Nov 12, 2026
DFIC 0.00% 85,611 $ 44.017K Nov 12, 2026